Clinical trialNCT06936566RecruitingPhase 2Interventional

MAGIC Ruxolitinib for aGVHD

SponsorJohn LevineEnrollment98Acute Graft-versus-host DiseaseAdverse EffectsAllogeneic Bone Marrow Transplantation

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

John Levine, MD, MS
Icahn School of Medicine at Mount Sinai
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope Comprehensive Cancer Center
Duarte, California, United States
Monzr Al Malki
Recruiting
Moffitt Cancer Center
Tampa, Florida, United States
Joseph Pidala
Not, yet, recruiting
Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
Amelia Langston
Recruiting
Kansas University Medical Center
Fairway, Kansas, United States
Umair Mushtaq, MD
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Corey Cutler →
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Zachariah DeFilipp
Recruiting
Mayo Clinic
Rochester, Minnesota, United States
William Hogan
Recruiting
Washington University
St Louis, Missouri, United States
Iskra Pusic
Not, yet, recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
John Levine
Recruiting
Ohio State University
Columbus, Ohio, United States
Hannah Choe
Not, yet, recruiting
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Elizabeth Hexner, MD
Not, yet, recruiting
Vanderbilt University
Nashville, Tennessee, United States
Carrie Kitko, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Amin Alousi
Recruiting
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Marco Mielcarek
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 May 2025
Primary completion: 1 Jun 2027
Completion: 14 Apr 2028
Last update posted: 23 Mar 2026
Registered enrollment: 98
Registry id: NCT06936566

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.